{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:57:31Z","timestamp":1792079851730,"version":"4.4.0"},"reference-count":50,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016046","name":"Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina","doi-asserted-by":"publisher","award":["142-451-3179\/2020-01"],"award-info":[{"award-number":["142-451-3179\/2020-01"]}],"id":[{"id":"10.13039\/501100016046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>The aim of this study was to determine and describe trends in antibiotics utilization in Serbia over a ten-year period. Data were retrieved from publicly available annual reports (2010\u20132019). The results were expressed as Defined Daily Dose (DDD) per 1000 inhabitants per day (DID). All calculations were performed using the DDD values for the 2020 Anatomical Therapeutic Chemical\/Defined Daily Dose (ATC\/DDD) version for each year of the study, to account for the DDD changes during the study period. Antibiotics were classified using the WHO Access, Watch, Reserve (AWaRe) classification. Total utilization of antibacterials for systemic use increased from 17.25 DID in 2010 to 28.65 DID in 2019. A statistically significant increasing trend in the use of the Watch category antibiotics was observed. A tendency towards use of broad-spectrum antibiotics, apparent by a statistically significant increase in the rate of utilization of broad-spectrum macrolides, quinolones and third-generation cephalosporins vs. narrow-spectrum ones, as well as a significant increasing trend in the use of quinolones was identified. Total antibiotic utilization was found to be well above the European average. Several specific problem areas were identified, which requires further efforts to improve antibiotic prescribing. The present study provides the information needed to facilitate antibiotic stewardship in Serbia further and proposes specific interventions to optimize antibiotic use in Serbia.<\/jats:p>","DOI":"10.3390\/antibiotics10040397","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T03:52:03Z","timestamp":1617767523000},"page":"397","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Increase and Change in the Pattern of Antibiotic Use in Serbia (2010\u20132019)"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2361-872X","authenticated-orcid":false,"given":"Ana","family":"Tomas","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-5830","authenticated-orcid":false,"given":"Neboj\u0161a","family":"Pavlovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0118-9418","authenticated-orcid":false,"given":"Neboj\u0161a","family":"Stilinovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Horvat","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Paut-Kusturica","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tihomir","family":"Dugand\u017eija","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia"},{"name":"Oncology Institute of Vojvodina, Put doktora Goldmana 4, 21204 Sremska Kamenica, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenko","family":"Tomi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sabo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1473-3099(18)30648-0","article-title":"Public health burden of antimicrobial resistance in Europe","volume":"19","author":"Tacconelli","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_2","unstructured":"World Health Organization (2015). Global Action Plan on Antimicrobial Resistance, World Health Organization."},{"key":"ref_3","unstructured":"World Health Organization (2019). Turning Plans into Action for Antimicrobial Resistance (AMR): Working Paper 2.0: Implementation and Coordination, World Health Organization."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fpubh.2018.00091","article-title":"Are There Striking Differences in Outpatient Use of Antibiotics Between South Backa District, Serbia, and Some Scandinavian Countries?","volume":"6","author":"Horvat","year":"2018","journal-title":"Front. Public Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/1120009X.2020.1755588","article-title":"Five-year surveillance and correlation of antibiotic consumption and resistance of Gram-negative bacteria at an intensive care unit in Serbia","volume":"32","author":"Tomas","year":"2020","journal-title":"J. Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11096-015-0071-x","article-title":"Home pharmacies in Serbia: An insight into self-medication practice","volume":"37","author":"Kusturica","year":"2015","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_7","unstructured":"Ministry of health of Republic of Serbia (2018). Working Group for the Development of National Good Clinical Practice Guideline for Rational Antibiotic Use, Ministry of health of Republic of Serbia."},{"key":"ref_8","unstructured":"World Health Organization (2019). Republic of Serbia: National Antibiotic Resistance Control Programme for the Period 2019\u20132021, World Health Organization."},{"key":"ref_9","unstructured":"Radonji\u0107, V., and Lj, \u0110. (2007). Trade and Consumption of the Medicinal Products\u2014Annual Reports 2006, Medicines and Medical Devices Agency of Serbia."},{"key":"ref_10","unstructured":"World Health Organization (2008). WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification Index-Including Defined Daily Doses (DDDs) for Plain Substances, WHO-Oslo."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11096-010-9366-0","article-title":"Coping with changes in the Defined Daily Dose in a longitudinal drug consumption database","volume":"32","author":"Gantumur","year":"2010","journal-title":"Pharm. World Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/jac\/dkz305","article-title":"What is the impact of the change in DDD of amoxicillin and amoxicillin combined with \u03b2-lactamase inhibitors on nationwide surveillance of antimicrobial use?","volume":"74","author":"Kusama","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_13","unstructured":"World Health Organization (2018). WHO Report on Surveillance of Antibiotic Consumption: 2016\u20132018 Early Implementation, World Health Organization."},{"key":"ref_14","unstructured":"Batut, M.J. (2021, March 27). Annual Report on Communicable Diseases. Available online: http:\/\/www.batut.org.rs\/download\/izvestaji\/GodisnjiIzvestajOZaraznimBolestima2018.pdf."},{"key":"ref_15","unstructured":"Institute for Health Metrics and Evaluation (IHME) (2021, March 27). Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. Available online: http:\/\/ghdx.healthdata.org\/gbd-results-tool."},{"key":"ref_16","unstructured":"European Centre for Disease Prevention and Control (2020). Antimicrobial Consumption: Annual Epidemiological Report for 2019."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sulis, G., Adam, P., Nafade, V., Gore, G., Daniels, B., Daftary, A., Das, J., Gandra, S., and Pai, M. (2020). Antibiotic prescription practices in primary care in low- and middle-income countries: A systematic review and meta-analysis. PLoS Med., 17.","DOI":"10.1371\/journal.pmed.1003139"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(17)30724-7","article-title":"Classifying antibiotics in the WHO Essential Medicines List for optimal use\u2014Be AWaRe","volume":"18","author":"Sharland","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_20","unstructured":"World Health Organization (2019). WHO Releases the 2019 AWaRe Classification Antibiotics, World Health Organization."},{"key":"ref_21","unstructured":"World Health Organization (2021, March 10). Adopt AWaRe: Handle Antibiotics with Care. Available online: https:\/\/adoptaware.org."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Gonz\u00e1lez, N.A., Di Gangi, S., Pichierri, G., Neuner-Jehle, S., Senn, O., and Plate, A. (2020). Time Trends and Factors Associated with Antibiotic Prescribing in Swiss Primary Care (2008 to 2020). Antibiotics, 9.","DOI":"10.3390\/antibiotics9110837"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jacamr\/dlaa048","article-title":"Community-level consumption of antibiotics according to the AWaRe (Access, Watch, Reserve) classification in rural Vietnam","volume":"2","author":"Nguyen","year":"2020","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Machado-Alba, J., Valladales-Restrepo, L., Gaviria-Mendoza, A., Machado-Duque, M., and Figueras, A. (2020). Patterns of Antibiotic Prescription in Colombia: Are There Differences between Capital Cities and Municipalities?. Antibiotics, 9.","DOI":"10.3390\/antibiotics9070389"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"AlJadeeah, S., Wirtz, V.J., and Nagel, E. (2020). Outpatient Antibiotic Dispensing for the Population with Government Health Insurance in Syria in 2018\u20132019. Antibiotics, 9.","DOI":"10.3390\/antibiotics9090570"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhussupova, G., Utepova, D., Orazova, G., Zhaldybayeva, S., Skvirskaya, G., and Tossekbayev, K. (2021). Evaluation of Antibiotic Use in Kazakhstan for the Period 2017\u20132019 Based on WHO Access, Watch and Reserve Classification (AWaRe 2019). Antibiotics, 10.","DOI":"10.3390\/antibiotics10010058"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40545-019-0182-1","article-title":"Need to improve availability of \u201caccess\u201d group antibiotics and reduce the use of \u201cwatch\u201d group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance","volume":"12","author":"Gandra","year":"2019","journal-title":"J. Pharm. Policy Pract."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2298\/VSP170731153P","article-title":"Inappropriate prescribing of antibiotics to the patients with acute bronchitis","volume":"76","author":"Bagi","year":"2019","journal-title":"Vojnosanit. Pregl."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/pds.1244","article-title":"The ESAC project group Antibiotic use in ambulatory care in Europe (ESAC data 1997\u20132002): Trends, regional differences and seasonal fluctuations","volume":"16","author":"Elseviers","year":"2006","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/512810","article-title":"European Surveillance of Antimicrobial Consumption Project Group Comparison of Outpatient Systemic Antibacterial Use in 2004 in the United States and 27 European Countries","volume":"44","author":"Goossens","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","unstructured":"(2021, March 10). Quality Indicators for Antibiotic Consumption in the Community. Available online: https:\/\/www.ecdc.europa.eu\/en\/antimicrobial-consumption\/database\/quality-indicators."},{"key":"ref_32","first-page":"1","article-title":"Antibiotic consumption and antimicrobial resistance in Poland; findings and implications","volume":"7","author":"Godman","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"ref_33","unstructured":"World Health Organization (2020). Central Asian and Eastern European Surveillance of Antimicrobial Resistance: Annual Report 2019, World Health Organization."},{"key":"ref_34","unstructured":"World Health Organization (2015). Central Asian and Eastern European Surveillance of Antimicrobial Resistance: Annual Report 2015, World Health Organization."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2471\/BLT.16.181743","article-title":"A time for action: Antimicrobial resistance needs global response","volume":"94","author":"Jinks","year":"2016","journal-title":"Bull. World Health Organ."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.idh.2017.12.002","article-title":"Antibiotic prescribing in primary healthcare: Dominant factors and trade-offs in decision-making","volume":"23","author":"Lum","year":"2018","journal-title":"Infect. Dis. Health"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/jac\/dku394","article-title":"Improve-ment of antibiotic prescription in outpatient care: A cluster-randomized intervention study using a sentinel surveillance network of physicians","volume":"70","author":"Limacher","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_38","first-page":"1","article-title":"Implementation and impact of pedi-atric antimicrobial stewardship programs: A systematic scoping review","volume":"9","author":"Barbieri","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1161\/CIR.0000000000000481","article-title":"ACC\/AHA special report: Clinical practice guideline implementation strategies: A summary of systematic reviews by the NHLBI Implementation Science Work Group: A report of the American College of Cardiolo-gy\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Chan","year":"2017","journal-title":"Circulation"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13012-018-0810-1","article-title":"Effectiveness of educational outreach visits compared with usual guideline dissemination to improve family physician prescribing\u2014an 18-month open clus-ter-randomized trial","volume":"13","author":"Pinto","year":"2018","journal-title":"Implement. Sci."},{"key":"ref_41","first-page":"CD010907","article-title":"Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care","volume":"2015","author":"Coxeter","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1586\/14787210.2016.1151353","article-title":"How can we improve antibiotic prescribing in primary care?","volume":"14","author":"Dyar","year":"2016","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1093\/jac\/dkz321","article-title":"Adaptation of the WHO Essential Medicines List for national antibiotic stewardship policy in England: Being AWaRe","volume":"74","author":"Budd","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3201\/eid1809.111515","article-title":"Control of Fluoroquinolone Resistance through Successful Regulation, Australia","volume":"18","author":"Cheng","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/cid\/ciy902","article-title":"The Impact of a National Antimicrobial Stewardship Program on Antibiotic Prescribing in Primary Care: An Interrupted Time Series Analysis","volume":"69","author":"Balinskaite","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2471\/BLT.16.184374","article-title":"Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance","volume":"95","author":"Carlin","year":"2017","journal-title":"Bull. World Health Organ."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12875-020-01191-0","article-title":"Antimicrobial stewardship in the primary care setting: From dream to reality?","volume":"21","author":"Avent","year":"2020","journal-title":"BMC Fam. Pract."},{"key":"ref_48","unstructured":"(2021, March 14). WHO Collaborating Centre for Drug Statistics Methodology. Available online: https:\/\/www.whocc.no\/atc_ddd_alterations__cumulative\/ddd_alterations\/."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s002280050431","article-title":"Drug utilization 90%\u2014A simple method for assessing the quality of drug prescribing","volume":"54","author":"Bergman","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/qshc.2006.021121","article-title":"The ESAC project group European Surveillance of Antimicrobial Consumption (ESAC): Quality indicators for outpatient antibiotic use in Europe","volume":"16","author":"Coenen","year":"2007","journal-title":"Qual. Saf. Health Care"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/4\/397\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:58:44Z","timestamp":1760363924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/4\/397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["antibiotics10040397"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics10040397","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]}}}